je.st
news
Tag: biotech
BBP: A Specialized Biotech ETF With Excellent Potential
2015-06-16 15:51:48| Biotech - Topix.net
There are biotech ETFs on the market, but they are relatively few, with offerings by State Street / SPDR , BlackRock / iShares , Van Eck / Market Vectors and others. On 16 December 2014, the ETF market saw the addition of two more biotechnology ETFs, one of which - BioShares Biotechnology Products ETF - will be the topic of this analysis.1 BBP is offered by LifeSci Index Partners under its BioShares banner and is structured so as to consist of only those biotechnology companies that have actual products on the market.
Tags: excellent
potential
specialized
biotech
Biotech Stocks Not Expensive Despite Long Bull Run
2015-06-15 22:09:25| Biotech - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: long
run
expensive
stocks
Nivalis Therapeutics A No-Brainer For Biotech Investors
2015-06-15 22:09:24| Biotech - Topix.net
Nivalis Therapeutics is a mid-clinical trial stage pharmaceutical company working with therapies that target certain gene mutations in cystic fibrosis patients. The company is preparing for its initial public offering to raise funds for continuing clinical trials and research.
Tags: investors
biotech
therapeutics
nobrainer
Two SD Biotech Companies To Be Recognized Nationally
2015-06-15 19:02:11| Biotech - Topix.net
Two South Dakota companies will be recognized this week at a national bioscience convention. The BIO International convention to promote the biotechnology industry is held in Philadelphia this week.
Tags: companies
recognized
nationally
biotech
Breaking down the biotech compensation boom
2015-06-15 14:53:30| Biotech - Topix.net
Roughly a month after it was reported that Vertex Pharmacetucials CEO Jeff Leiden received compensation in 2014 that included a $1.1 million salary, $14.9 million in value from a one-time restricted stock grant and $22.9 million in stock awards and bonuses, the pay parade has continued for senior executives at other major biotech and life sciences companies.
Tags: compensation
breaking
boom
biotech
Sites : [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] next »